COLUMBUS CIRCLE INVESTORS - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
COLUMBUS CIRCLE INVESTORS ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$8,071,000
-41.0%
80,990
-32.0%
0.44%
-24.5%
Q4 2019$13,687,000
+16.4%
119,122
+27.8%
0.59%
+36.1%
Q3 2019$11,759,000
+29.9%
93,224
+23.9%
0.43%
+78.5%
Q2 2019$9,054,000
-63.4%
75,234
-69.6%
0.24%
-65.5%
Q4 2018$24,744,000
-28.4%
247,320
-18.0%
0.70%
+1.6%
Q3 2018$34,575,000
+47.9%
301,752
+15.8%
0.69%
+42.9%
Q2 2018$23,378,000
+60.3%
260,678
+30.8%
0.48%
+63.2%
Q1 2018$14,581,000199,3030.30%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders